Live Breaking News & Updates on ஹட்சன் சாண்ட்லர்

Stay updated with breaking news from ஹட்சன் சாண்ட்லர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The World's First Study Of A Combination Between The AstraZeneca Vaccine And The First Component Of The Sputnik V Vaccine (Sputnik Light) In Azerbaijan Shows No Serious Adverse Events Or COVID Infection Cases Following The Vaccination


(1)
MOSCOW, July 30, 2021 /PRNewswire/ The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund) announces initial safety results of the world s first study of a combination between the AstraZeneca vaccine (developed jointly with the University of Oxford) and the first component of the Sputnik V vaccine (Sputnik Light vaccine based on human adenovirus serotype 26) in the Republic of Azerbaijan.
The heterogeneous boosting approach ( vaccine cocktail using human adenovirus serotype 26 as the first component and human adenovirus serotype 5 as the second component) was at the core of Sputnik V, the world s first registered vaccine against coronavirus. With this approach proving successful in creating a longer and more durable immunity against the coronavirus, RDIF took the lead in initiating partnerships with other vaccine producers to conduct joint studies of a combination of the first component of Sputnik V with foreign vaccines. ....

Republic Of Azerbaijan , Russian Federation , Andrew Leach Maria Shiryaevskaya , Alexey Urazov , Irina Panarina , Kirill Dmitriev , Vladimir Putin , Hudson Sandler , University Of Oxford , R Pharm Group , Gamaleya Center , Russian Direct Investment Fund , Sputnik Light , Russia Vladimir , General Manager , Astrazeneca Russia , Direct Investment Fund , குடியரசு ஆஃப் அஜர்பைஜான் , ரஷ்ய கூட்டமைப்பு , விளாடிமிர் புட்டின் , ஹட்சன் சாண்ட்லர் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ர் பார்ம் குழு , ரஷ்ய நேரடி முதலீடு நிதி , ஸ்பட்நிக் ஒளி , ரஷ்யா விளாடிமிர் ,